Flinton Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$103M Sell
1,281,790
-18,992
-1% -$1.52M 3.19% 3
2019
Q2
$104M Sell
1,300,782
-88,260
-6% -$6.76M 3.28% 3
2019
Q1
$110M Buy
1,389,042
+210,335
+18% +$15.7M 3.62% 2
2018
Q4
$85.9M Buy
1,178,707
+409,234
+53% +$28.9M 3.25% 2
2018
Q3
$52.1M Buy
769,473
+643,906
+513% +$41M 1.61% 6
2018
Q2
$7.27M Buy
125,567
+33,066
+36% +$1.87M 0.24% 93
2018
Q1
$4.81M Buy
92,501
+7,804
+9% +$421K 0.16% 118
2017
Q4
$4.55M Buy
84,697
+7,589
+10% +$421K 0.15% 125
2017
Q3
$4.71M Sell
77,108
-95,957
-55% -$5.82M 0.17% 123
2017
Q2
$10.6M Sell
173,065
-105,720
-38% -$6.44M 0.39% 61
2017
Q1
$16.9M Buy
278,785
+10,797
+4% +$655K 0.65% 35
2016
Q4
$15.1M Buy
+267,988
New +$15.7M 0.66% 33

Other funds holding MRK

Flinton Capital Management's MRK Position: Q3 2019 in Review

Flinton Capital Management reduced its Merck (MRK) stake by 1.5% in Q3 2019, selling an estimated $1.52M and leaving 1,281,790 shares worth $103M. The position accounts for 3.19% of the portfolio, ranked #3.

Flinton Capital Management first reported a position in MRK in Q4 2016 and has held it in 12 quarters since. The position peaked at $110M in Q1 2019. 2,305 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

  • Flinton Capital Management held 1,281,790 shares of Merck worth $103M as of Q3 2019.
  • Flinton Capital Management sold 18,992 Merck shares in Q3 2019, an estimated $1.52M.
  • Merck made up 3.19% of Flinton Capital Management's portfolio in Q3 2019, its #3 holding.
  • Flinton Capital Management first reported a position in Merck in Q4 2016 and has held it in 12 quarters since.
  • Flinton Capital Management's Merck position peaked at $110M in Q1 2019.
  • 2,305 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.